Home/Bills/A 10211New York · 2025–2026 Legislative Session
Assembly BillIntroducedISC

A 10211: Requires medicaid and insurers to include coverage for testing of PFAS levels in blood; defines PFAS.

New York · Assembly · 2025–2026 Legislative Session · last verified March 26, 2026

What A 10211 does, verified March 26, 2026

The bill aims to provide insurance coverage for testing of per- and polyfluoroalkyl substances (PFAFs) in blood. PFAFs are chemicals found in non-stick cookware, food packaging, and other consumer products. The bill requires insurance policies to cover testing for PFAFs in blood if ordered by a licensed healthcare provider. This coverage includes medical, major medical, and similar comprehensive-type coverage. The bill also applies to medical expense indemnity corporations and health service corporations. In addition, the bill requires medical assistance to include PFAF testing in blood if ordered by a licensed healthcare provider, but excludes coverage in the absence of federal financial participation. The bill takes effect on January 1, 2027, and applies to all policies and contracts issued, renewed, modified, altered or amended on or after that date.

Bill journey
1IntroducedCurrent
2In CommitteePending
3First Chamber FloorPending
4Second ChamberPending
5GovernorPending
6ChapteredPending
Last action: referred to insurance (2026-02-12)Alert me
Quick answers about A 10211
What is the current status of A 10211?
As of March 26, 2026, A 10211 is recorded as "Introduced": it has been introduced and is waiting for its first committee hearing or floor vote. The last recorded action, on February 12, 2026, was "referred to insurance".
Did A 10211 pass?
Not yet. A 10211 has been introduced and has not passed either house.
Who wrote A 10211, and where is it now?
A 10211 was authored by Asm. Anna Kelles with 5 coauthors. Its committee of record is Assembly Insurance. It is filed under ISC, alongside 202 other New York ISC bills this session.
Author and sponsors
Full contact details, staff, and committees with Connect, $16/moUnlock
Coauthors
Chris BurdickPaula Elaine KayTommy John SchiavoniJo Anne SimonDana Levenberg
Recent actions1 total · showing 1
Feb. 12, 2026referred to insurance
Latest bill textIntroduced version, February 12, 2026 · 543 words
  
  STATE OF NEW YORK ________________________________________________________________________ 10211  IN ASSEMBLY February 12, 2026 ___________ Introduced by M. of A. KELLES -- read once and referred to the Committee on Insurance AN ACT to amend the insurance law and the social services law, in relation to insurance coverage for testing for PFAS levels in blood The People of the State of New York, represented in Senate and Assem- bly, do enact as follows: 1 Section 1. Subsection (i) of section 3216 of the insurance law is 2 amended by adding a new paragraph 42 to read as follows: 3 (42) (A) Every policy which provides medical, major medical, or simi- 4 lar comprehensive-type coverage shall provide coverage for testing of 5 PFAS levels in blood if ordered by a physician or other licensed health 6 care provider legally authorized to order such testing under title eight 7 of the education law. 8 (B) For the purposes of this paragraph, "PFAS" means perfluoroalkyl 9 and polyfluoroalkyl substances. 10 § 2. Subsection (k) of section 3221 of the insurance law is amended by 11 adding a new paragraph 24 to read as follows: 12 (24) (A) Every policy which provides medical, major medical, or simi- 13 lar comprehensive-type coverage shall provide coverage for testing of 14 PFAS levels in blood if ordered by a physician or other licensed health 15 care provider legally authorized to order such testing under title eight 16 of the education law. 17 (B) For the purposes of this paragraph, "PFAS" means perfluoroalkyl 18 and polyfluoroalkyl substances. 19 § 3. Section 4303 of the insurance law is amended by adding a new 20 subsection (xx) to read as follows: 21 (xx) (A) A medical expense indemnity corporation or a health service 22 corporation which provides medical, major medical or similar comprehen- 23 sive-type coverage shall include coverage for testing of PFAS levels in 24 blood if ordered by a physician or other licensed health care provider 25 legally authorized to order such testing under title eight of the educa- 26 tion law. 27 (B) For the purposes of this paragraph, "PFAS" means perfluoroalkyl 28 and polyfluoroalkyl substances. EXPLANATION--Matter in italics (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD14314-01-5 

 A. 10211 2 1 § 4. Subdivision 2 of section 365-a of the social services law is 2 amended by adding a new paragraph (oo) to read as follows: 3 (oo) (i) (1) Medical assistance shall include testing of PFAS levels 4 in blood if ordered by a physician or other licensed health care provid- 5 er legally authorized to order such testing under title eight of the 6 education law. 7 (2) For the purposes of this paragraph, "PFAS" means perfluoroalkyl 8 and polyfluoroalkyl substances. 9 (ii) In the event that federal financial participation for such test- 10 ing of PFAS in blood is not available, medical assistance shall not 11 include coverage of these services. 12 § 5. This act shall take effect the first of January next succeeding 13 the date on which it shall have become a law and shall apply to all 14 policies and contracts issued, renewed, modified, altered or amended on 15 or after such effective date. 

Text of A 10211 as introduced, from the official record. Connect Plus keeps every version and highlights what changed.Compare versions
GovBuddy Demo

See how GovBuddy fits your team.

Share a few details and our team will follow up with a focused walkthrough.